Education
About Us
Working with TipRanks
Follow Us
Aroa Biosurgery Ltd (AU:ARX)
ASX:ARX
RESEARCH TOOLSreports
Total Valuation
Aroa Biosurgery Ltd has a market cap or net worth of AU$155.21M. The enterprise value is AU$179.06M.
Market CapAU$155.21M
Enterprise ValueAU$179.06M
Share Statistics
Aroa Biosurgery Ltd has 344,900,270 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding344,900,270
Owned by Insiders0.17%
Owned by Institutions―
Financial Efficiency
Aroa Biosurgery Ltd’s return on equity (ROE) is -0.11 and return on invested capital (ROIC) is -10.61%.
Return on Equity (ROE)-0.11
Return on Assets (ROA)-0.10
Return on Invested Capital (ROIC)-10.61%
Return on Capital Employed (ROCE)-0.11
Revenue Per Employee―
Profits Per Employee―
Employee Count―
Asset Turnover0.62
Inventory Turnover1.25
Valuation Ratios
The current PE Ratio of Aroa Biosurgery Ltd is -19.75. Aroa Biosurgery Ltd’s PEG ratio is >-0.01.
PE Ratio-19.75
PS Ratio0.00
PB Ratio2.21
Price to Fair Value2.21
Price to FCF-14.46
Price to Operating Cash Flow-28.16
PEG Ratio>-0.01
Income Statement
In the last 12 months, Aroa Biosurgery Ltd had revenue of 63.36M and earned -9.75M in profits. Earnings per share was -0.03.
Revenue63.36M
Gross Profit54.10M
Operating Income-9.79M
Pretax Income-9.56M
Net Income-9.75M
EBITDA-7.36M
Earnings Per Share (EPS)-0.03
Cash Flow
In the last 12 months, operating cash flow was -4.46M and capital expenditures -2.74M, giving a free cash flow of -5.89M billion.
Operating Cash Flow-4.46M
Free Cash Flow-5.89M
Free Cash Flow per Share-0.02
Dividends & Yields
Aroa Biosurgery Ltd pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.47
52-Week Price Change-16.67%
50-Day Moving Average0.46
200-Day Moving Average0.57
Relative Strength Index (RSI)54.74
Average Volume (3m)481.32K
Important Dates
Aroa Biosurgery Ltd upcoming earnings date is Nov 25, 2024, TBA Not Confirmed.
Last Earnings DateMay 20, 2024
Next Earnings DateNov 25, 2024
Ex-Dividend Date―
Financial Position
Aroa Biosurgery Ltd as a current ratio of 7.26, with Debt / Equity ratio of 7.48%
Current Ratio7.26
Quick Ratio6.40
Debt to Market Cap0.00
Net Debt to EBITDA0.51
Interest Coverage Ratio-8.41
Taxes
In the past 12 months, Aroa Biosurgery Ltd has paid 184.39K in taxes.
Income Tax184.39K
Effective Tax Rate-0.02
Enterprise Valuation
Aroa Biosurgery Ltd EV to EBITDA ratio is -25.65, with an EV/FCF ratio of -14.18.
EV to Sales2.98
EV to EBITDA-25.65
EV to Free Cash Flow-14.18
EV to Operating Cash Flow-27.62
Balance Sheet
Aroa Biosurgery Ltd has AU$20.12M in cash and marketable securities with AU$10.53M in debt, giving a net cash position of -AU$13.79M billion.
Cash & Marketable SecuritiesAU$20.12M
Total DebtAU$10.53M
Net Cash-AU$13.79M
Net Cash Per Share-AU$0.04
Tangible Book Value Per ShareAU$0.20
Margins
Gross margin is 86.63%, with operating margin of -15.45%, and net profit margin of -15.39%.
Gross Margin86.63%
Operating Margin-15.45%
Pretax Margin-15.10%
Net Profit Margin-15.39%
EBITDA Margin-11.62%
EBIT Margin-13.26%
Analyst Forecast
The average price target for Aroa Biosurgery Ltd is AU$0.80, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price TargetAU$0.80
Price Target Upside77.78% Upside
Analyst ConsensusModerate Buy
Analyst Count2
Revenue Growth Forecast15.90%
EPS Growth Forecast8.52%